Literature DB >> 19747707

N-terminally truncated C protein, CNDelta25, of human parainfluenza virus type 3 is a potent inhibitor of viral replication.

Hongxia Mao1, Santanu Chattopadhyay, Amiya K Banerjee.   

Abstract

The C protein of human parainfluenza virus type 3 (HPIV3) is a multifunctional accessory protein that inhibits viral transcription and interferon (IFN) signaling. In the present study, we found that removal of N-terminal 25 or 50 amino acid residues from the C protein (CNDelta25 or CNDelta50) totally abolished viral RNA synthesis in the HPIV3 minigenome system. Further N-terminal or C-terminal deletion impaired the inhibitory ability of CNDelta25 and CNDelta50. Subsequent mutagenesis analysis suggested that the N-terminal-charged amino acid residues (K3, K6, K12, E16, and R24) contribute to the higher inhibition caused by CNDelta25 than the C protein. Consistent with viral RNA synthesis inhibition, the growth of HPIV3 was significantly decreased by 5 logs in HeLa-derived cell line expressing CNDelta25. Interestingly, replication of respiratory syncytial virus (RSV), another important respiratory tract pathogen, was also strongly inhibited in the presence of CNDelta25. These findings provide a promising potential to use CNDelta25 as an antiviral agent against the clinically important respiratory tract diseases caused by HPIV3 and RSV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747707      PMCID: PMC2767389          DOI: 10.1016/j.virol.2009.08.026

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  30 in total

1.  Sendai virus wild-type and mutant C proteins show a direct correlation between L polymerase binding and inhibition of viral RNA synthesis.

Authors:  C C Grogan; S A Moyer
Journal:  Virology       Date:  2001-09-15       Impact factor: 3.616

2.  Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice.

Authors:  Atsushi Kato; Katsuhiro Kiyotani; Toru Kubota; Tetsuya Yoshida; Masato Tashiro; Yoshiyuki Nagai
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

3.  Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis.

Authors:  A Kato; Y Ohnishi; M Kohase; S Saito; M Tashiro; Y Nagai
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Precise mapping of the replication and transcription promoters of human parainfluenza virus type 3.

Authors:  M A Hoffman; A K Banerjee
Journal:  Virology       Date:  2000-03-30       Impact factor: 3.616

5.  Measles virus circumvents the host interferon response by different actions of the C and V proteins.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Shinji Ohno; Yuta Shirogane; Masaharu Iwasaki; Yusuke Yanagi
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

Review 6.  Current status of vaccines for parainfluenza virus infections.

Authors:  Masatoki Sato; Peter F Wright
Journal:  Pediatr Infect Dis J       Date:  2008-10       Impact factor: 2.129

7.  The C, V and W proteins of Nipah virus inhibit minigenome replication.

Authors:  Katrina Sleeman; Bettina Bankamp; Kimberly B Hummel; Michael K Lo; William J Bellini; Paul A Rota
Journal:  J Gen Virol       Date:  2008-05       Impact factor: 3.891

8.  Inhibition of human parainfluenza virus type 3 infection by novel small molecules.

Authors:  Hongxia Mao; Chandar S Thakur; Santanu Chattopadhyay; Robert H Silverman; Andrei Gudkov; Amiya K Banerjee
Journal:  Antiviral Res       Date:  2007-10-02       Impact factor: 5.970

Review 9.  Respiratory viruses other than influenza virus: impact and therapeutic advances.

Authors:  W Garrett Nichols; Angela J Peck Campbell; Michael Boeckh
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

10.  Expression of human parainfluenza virus type 3 PD protein and intracellular localization in virus infected cells.

Authors:  Greg Wells; Achut Malur
Journal:  Virus Genes       Date:  2008-08-27       Impact factor: 2.198

View more
  6 in total

Review 1.  Hendra and nipah infection: pathology, models and potential therapies.

Authors:  Frederic Vigant; Benhur Lee
Journal:  Infect Disord Drug Targets       Date:  2011-06

2.  Domain within the C protein of human parainfluenza virus type 3 that regulates interferon signaling.

Authors:  Hongxia Mao; Santanu Chattopadhyay; Amiya K Banerjee
Journal:  Gene Expr       Date:  2010

3.  Current management of parainfluenza pneumonitis in immunocompromised patients: a review.

Authors:  Ann R Falsey
Journal:  Infect Drug Resist       Date:  2012-08-08       Impact factor: 4.003

Review 4.  Parainfluenza Virus Infection.

Authors:  Angela R Branche; Ann R Falsey
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

5.  Evolution and structural organization of the C proteins of paramyxovirinae.

Authors:  Michael K Lo; Teit Max Søgaard; David G Karlin
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

Review 6.  C Proteins: Controllers of Orderly Paramyxovirus Replication and of the Innate Immune Response.

Authors:  Oliver Siering; Roberto Cattaneo; Christian K Pfaller
Journal:  Viruses       Date:  2022-01-12       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.